Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Abraxis BioScience, LLC, a wholly-owned subsidiary of Celgene Corporation

Femme Max 99 ans
Abraxis BioScience, LLC, a wholly-owned subsidiary of Celgene Corporation MAJ Il y a 4 ans

Clinical study for patients with breast cancer that has spread to other parts of the body and that does not respond to hormonal or anti-HER2 therapy ('triple negative disease'), comparing a chemotherapy treatment (carboplatin + gemcitabine) with an experimental treatment of nab-paclitaxel plus chemotherapy (carboplatin OR gemcitabine) - Phase 2: evaluate the benefit and risk profiles of the two nab-paclitaxel experimental arms and identify the nab-paclitaxel combination that will be used in the Phase 3. - Phase 3: compare the p...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations

Femme et Homme Max 99 ans
Abraxis BioScience, LLC, a wholly-owned subsidiary of Celgene Corporation MAJ Il y a 4 ans

A clinical trial to compare the safety and effectiveness of Abraxane versus dacarbazine, in the treatment of advanced stage melanoma that has spread to other parts of the body (metastatic malignant melanoma) The primary objective of this study is to compare the following regimens with respect to antitumor activity in patients who are previously untreated with cytotoxic chemotherapy for metastatic malignan...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations